Literature DB >> 12666692

Influence of surgeon's volume on early outcome after total gastrectomy.

Tetsujl Fujita1, Yoji Yamazaki.   

Abstract

OBJECTIVE: To examine correlation between number of total gastrectomies done by each of 21 surgeons and the early outcome of these operations.
DESIGN: Retrospective case series.
SETTING: University hospital, Japan. PATIENTS: 136 patients treated by total gastrectomy for gastric cancer during a 4-year period. INTERVENTION: Univariate and multivariate analyses of the effect of each surgeon's volume on the early outcome of total gastrectomy. MAIN OUTCOME MEASURES: Differences in the morbidity and mortality after total gastrectomy between high-volume and low-volume surgeons.
RESULTS: There was a significant difference in the incidence of major complications of total gastrectomy between high-volume (7/66, 11%) and low-volume (17/70, 24%) surgeons (p = 0.04).
CONCLUSION: Possible reasons for differences in outcome between high-volume and low-volume surgeons should be investigated in an attempt to define and describe the methods that are associated with the best outcome.

Entities:  

Mesh:

Year:  2002        PMID: 12666692

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  3 in total

1.  Operating lists are created by rational algorithms and use of power. What can a social scientific view offer surgeons?

Authors:  Carsten Engelmann; Gudela Grote; Siegfried Geyer; Dzifa Ametowobla
Journal:  Langenbecks Arch Surg       Date:  2016-10-14       Impact factor: 3.445

2.  Associations of centralization with health care quality for gastric cancer patients receiving gastrectomy in China.

Authors:  Jiafu Ji; Leiyu Shi; Xiangji Ying; Xinpu Lu; Fei Shan; Haibo Wang
Journal:  Chin J Cancer Res       Date:  2021-12-31       Impact factor: 5.087

Review 3.  Associations of Annual Hospital and Surgeon Volume with Patient Outcomes After Gastrectomy: A Systematic Review and Meta-analysis.

Authors:  Jiafu Ji; Leiyu Shi; Xiangji Ying; Xinpu Lu; Fei Shan
Journal:  Ann Surg Oncol       Date:  2022-09-15       Impact factor: 4.339

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.